Agora Labs raises EUR 4.3m to open hospital data to research

Agora Labs raises EUR 4.3m to open hospital data to research

27 October 2026: Agora Labs, an Italian deeptech company, has raised EUR 4.3 million in a round led by the venture firm P101 SGR. The Mussetto family, owners of the holding company Infinite Five, which invests in martech, data analysis and robotics, also took part. P101 says it is the 17th investment made through its Programma 103 fund, which is supported by the EU's InvestEU programme.

Not yet independently verified. This rests on the investor's announcement; we have not seen a statement on Agora Labs' own site. The network size, the Saudi project and the hiring plan are as the parties state them. The page does not name the company's headquarters city, so we do not give one. We will update this when it can be confirmed, and remove this note.

Agora builds infrastructure that lets hospitals use their own clinical data for medical and scientific research while protecting patient privacy.

How the data stays inside the hospital

The design starts from the idea that patient records should not leave the building. Each facility hosts an on-premise computing node with NVIDIA GPUs. Specialised large language models running on that node structure and standardise the data on site, and the data is then anonymised with irreversible mathematical methods that P101 says are built to resist quantum computing attacks.

Researchers do not receive the records. Federated learning lets them run multicentre studies in which models train locally at each hospital and only the outputs and inferences are shared.

A network of 50 facilities

P101 says the network already includes 50 healthcare facilities, among them Harvard Medical School and San Raffaele Hospital in Milan, and that Agora plans to double that number in the coming months. Two projects are named. In Italy, the company is analysing hospital pharmacy and care pathway data to compare healthcare models. In Saudi Arabia, it is combining genetic, clinical and radiological data to build predictive models for complications of type 1 and type 2 diabetes.

The company was founded in Rome by Davide Zaccagnini and Fabio Giulietto and grew out of a European research project on secure clinical data sharing, begun after GDPR took effect in 2018. It has operated commercially since 2023.

What the money is for

The funding is meant to strengthen Agora's presence in Europe and the US and to open the Middle East and India. About 20 technical and commercial staff are expected to join in the coming months. Zaccagnini says the new investors address two needs: growing the data network faster and running projects at global scale. Stefano Guidotti, a partner at P101, calls the solution unique in Europe and says AI-enabled healthcare is a core thesis for the firm.

P101 places the company in real world evidence, the use of data from everyday clinical practice, and quotes an estimate that this market will grow from $5.4 billion in 2025 to $10.8 billion in 2030. That is a forecast cited by the investor, not a finding.

For hospital data protection officers, the useful questions are what exactly leaves the node, how anonymisation is tested, and who is responsible under GDPR when a model trained across sites is shared.

Related on TrustList:

• Maggioli Group takes 20% of Turin clinical AI start-up DatAIMed
• Vera Health raises $28.5m Series A for clinical evidence search

Sources

• P101: P101 leads a EUR 4.3 million round in Agora Labs, the Italian deeptech company serving global healthcare, 27 October 2026